Visionary Wealth Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Sell |
23,090
-3,500
| -13% | -$31.4K | 0.01% | 552 |
|
|
2025
Q1 | $199K | Hold |
26,590
| – | – | 0.01% | 522 |
|
|
2024
Q4 | $200K | Sell |
26,590
-1,200
| -4% | -$9.02K | 0.01% | 521 |
|
|
2024
Q3 | $211K | Sell |
27,790
-450
| -2% | -$3.42K | 0.01% | 503 |
|
|
2024
Q2 | $175K | Sell |
28,240
-300
| -1% | -$1.85K | 0.01% | 492 |
|
|
2024
Q1 | $145K | Hold |
28,540
| – | – | 0.01% | 475 |
|
|
2023
Q4 | $171K | Sell |
28,540
-5,000
| -15% | -$30K | 0.01% | 462 |
|
|
2023
Q3 | $237K | Sell |
33,540
-5,000
| -13% | -$35.4K | 0.02% | 406 |
|
|
2023
Q2 | $271K | Sell |
38,540
-1,400
| -4% | -$9.86K | 0.02% | 380 |
|
|
2023
Q1 | $333K | Buy |
39,940
+140
| +0.4% | +$1.17K | 0.03% | 335 |
|
|
2022
Q4 | $457K | Buy |
39,800
+750
| +2% | +$8.61K | 0.04% | 252 |
|
|
2022
Q3 | $492K | Sell |
39,050
-5,400
| -12% | -$68K | 0.05% | 229 |
|
|
2022
Q2 | $470K | Buy |
44,450
+4,950
| +13% | +$52.3K | 0.04% | 246 |
|
|
2022
Q1 | $642K | Sell |
39,500
-5,625
| -12% | -$91.4K | 0.05% | 223 |
|
|
2021
Q4 | $625K | Buy |
45,125
+3,650
| +9% | +$50.6K | 0.05% | 208 |
|
|
2021
Q3 | $596K | Buy |
41,475
+15,275
| +58% | +$220K | 0.06% | 172 |
|
|
2021
Q2 | $414K | Buy |
26,200
+8,000
| +44% | +$126K | 0.04% | 221 |
|
|
2021
Q1 | $185K | Buy |
+18,200
| New | +$185K | 0.02% | 310 |
|